Skip to main content
When
10:00 AM Pacific
11:00 AM Pacific

Presented by the Parkinson’s Foundation, as part of their Expert Briefings series.

Register now for FREE

Includes 1 complimentary CE credit*

*ASWB CE Credit Changes 2018: Beginning September 25, 2018, ASA will no longer be able to  issue ASWB CE credits for recorded web seminar attendance. You can only claim ASWB CE credit if you watch “Parkinson’s Disease and Medication: What’s New?” at 10:00 AM PT on April 9, 2019. We apologize for any inconvenience. This change is due to ASWB ACE Provider distance learning requirements.

If you require ADA accommodation to participate in this web seminar, please contact Steve Moore at your earliest convenience to make arrangements – smoore@asaging.org

Medication options for Parkinson’s disease are constantly evolving and vary for each individual. Choosing medications depends upon many variables; including motor fluctuations, symptom variability and other existing health issues. In this web seminar, Dr. Rajesh Pahwa will share treatment options on the horizon within the next two years, and explains the best candidates for these new therapies when they become available.

Participants in this web seminar will be able to:

  • Describe new treatment options available in the next two years; and,
  • Understand who would be the best candidates for the new therapies.

Presenters:

Rajesh%20Pahwa.pngDr. Rajesh Pahwa is the Laverne and Joyce Rider Professor of Neurology at the University of Kansas Medical Center. He is also chief, Parkinson and Movement Disorder Division and director of Parkinson Foundation Center of Excellence at the University of Kansas Medical Center in Kansas City, Kansas.

Target Audience: All

PLEASE NOTE: This web seminar is being hosted by the Parkinson’s Foundation, and registration will be handled through their website, www.parkinson.org.

Questions about registration? Call the Parkinson’s Foundation at 800-457-6676. 

Questions about CEs? Call ASA at 415-974-9628.

Have technical issues? Call NetBriefings at 866-225-1532